.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Novartis
Accenture
Harvard Business School
McKesson
Fish and Richardson
US Department of Justice
Express Scripts
McKinsey
Chubb

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,211,244

« Back to Dashboard

Summary for Patent: 6,211,244

Title: Calcium receptor-active compounds
Abstract:The present invention features compounds able to modulate one or more activities of an inorganic ion receptor and methods for treating diseases or disorders by modulating inorganic ion receptor activity. Preferably, the compound can mimic or block the effect of extracellular Ca.sup.2+ on a calcium receptor.
Inventor(s): Van Wagenen; Bradford C. (Salt Lake City, UT), Moe; Scott T. (Salt Lake City, UT), Balandrin; Manuel F. (Sandy, UT), DelMar; Eric G. (Salt Lake City, UT), Nemeth; Edward F. (Salt Lake City, UT)
Assignee: NPS Pharmaceuticals, Inc. (Salt Lake City, UT)
Application Number:08/546,998
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

No matches for this query

International Patent Family for Patent: 6,211,244

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office1281702► Subscribe
Australia1014100► Subscribe
Australia3122699► Subscribe
Australia4195796► Subscribe
Australia8124294► Subscribe
Brazil9408298► Subscribe
Brazil9509411► Subscribe
Canada2115828► Subscribe
Canada2173747► Subscribe
Canada2178743► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Teva
Deloitte
Moodys
Argus Health
Johnson and Johnson
Cantor Fitzgerald
Healthtrust
Queensland Health
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot